Brain+ A/S (CPH:BRAINP)
Denmark · Delayed Price · Currency is DKK 0.0128
-0.0008 (-5.88%)
Oct 16, 2025, 2:34 PM CET
Brain+ Market Cap
Brain+ has a market cap or net worth of 15.41 million as of October 16, 2025. Its market cap has increased by 5.70% in one year.
Market Cap
15.41M
Enterprise Value
11.06M
Revenue
5.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since October 7, 2021, Brain+'s market cap has decreased from 51.99M to 15.41M, a decrease of -70.36%. That is a compound annual growth rate of -26.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 15.41M | -22.71% |
| Dec 30, 2024 | 19.94M | 56.98% |
| Dec 29, 2023 | 12.70M | -37.15% |
| Dec 30, 2022 | 20.21M | -50.00% |
| Dec 30, 2021 | 40.41M | -22.27% |
| Oct 7, 2021 | 51.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,602.52B |
| Coloplast | 128.89B |
| Genmab | 127.79B |
| Demant | 47.76B |
| ALK-Abelló | 46.14B |
| H. Lundbeck | 43.50B |
| Zealand Pharma | 33.86B |
| Ambu A/S | 26.75B |